25th Anniversary Congress Berlin, Germany
Berlin Congress Centre bcc 17 to 20 October 2017
ESGCT SOCIETY MEMBERSHIP
Registration for ESGCT annual meeting in collaboration with DG-GT e.V.
More information on the programme and practicalities are available on the Berlin page.
Step forward for gene editing in human embryos
Mechanoresponsive stem cells target cancer metastases
Gene addition of micro-dystrophin improves Duchenne muscular dystrophy symptoms in dogs
Proof of concept for new strategy of genome editing to correct splice-site mutations
Step forward for precision medicine - personalised anti-cancer vaccine tested in patients
Genome editing used to treat Huntington's disease in mice
New developments in blood cell therapy
First clinical trial with in vivo genome editing
Phase I trial of gene therapy for age-related macular degeneration completed
ESGCT welcomes two Student Board Members
Feng Zhang Discusses CRISPR and Future of Gene Editing in Interview in Human Gene Therapy
New gene therapy success in a rare disease of the immune system: Wiskott-Aldrich syndrome
First stem-cell therapy recommended for approval in EU
Innovations in Oncology: 3rd International Symposium
Course: Clinical application of CAR T-cells
Do you want to see your job posted here?
A step towards treatment of congenital deafness with gene therapy
Treating allergy with a single vaccine?
Involving patients in research, we can and should
2017 ESGCT Spring School - Granada, Spain - 5 to 7 April 2017
Copyright ©2016 European Society for Gene and Cell Therapy | Website by OFEC